News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Amol Akhade: What is interesting in ASCO GU25
Amol Akhade/LinkedIn
Feb 8, 2025, 12:17

Amol Akhade: What is interesting in ASCO GU25

Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on LinkedIn:

“What is interesting in ASCO GU25.

1 – Surgery vs RT for High Risk Prostate cancer. -IPD Data from 2 RCT
2 – OS for checkmate274
3 – PCR analysis for Nigeria trial
4 – Final OS for Talapro-2 trial
5 – management of biochemical recurrence after RT for localized ca prostate.
6 – management of oligometastatic prostate cancer.”

Amol Akhade ASCO GU25 cancer Nigeria trial OncoDaily Oncology prostate cancer TALAPRO-2 trial
Special Coverage
Science
Mar 11, 2025, 16:56
Ajay Major: Patient and care partner perspectives on treatment decision-making in NLPHL
Blog
Mar 11, 2025, 16:48
How to make your abstract stand out at SIOP 2025
Blog
Mar 11, 2025, 16:33
The first episode of the Diary of an Oncology Leader series - ESMO
Blog
Mar 11, 2025, 16:24
Olubukola Ayodele: Cancer care should be about healing the whole person
Oncolibrary
Mar 11, 2025, 16:02
VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer
Blog
Mar 11, 2025, 15:02
Paolo Tarantino: A pleasure to join the gender balance session at JSMO25
Blog
Mar 11, 2025, 15:01
Chronic stress and obesity work together to accelerate pancreatic cancer development and growth
Science
Mar 11, 2025, 14:59
Angela Mastronuzzi: Gender role in radiotherapy - Single-centre report on adult and paediatric oncological patients
Positive
Mar 11, 2025, 14:44
BCRF tributes women who transformed breast cancer research
Science
Mar 11, 2025, 14:12
Nieves Martinez Lago: PEM in MSI and dMMR advanced solid tumors
Blog
Mar 11, 2025, 14:11
Muhammad Umair Mushtaq: Graft Cell Dose in Haploidentical PBSC with Post-Transplant Cyclophosphamide
Blog
Mar 11, 2025, 13:57
Good Health should never be out of reach - City Cancer Challenge